Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Vifor Pharma AG (VIFN.SW)

Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
168.95+0.40 (+0.24%)
At close: 05:30PM CEST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close168.55
Open169.45
Bid0.00 x 0
Ask0.00 x 0
Day's Range168.55 - 169.45
52 Week Range102.30 - 197.20
Volume14,875
Avg. Volume42,161
Market Cap11.025B
Beta (5Y Monthly)1.37
PE Ratio (TTM)26.38
EPS (TTM)6.40
Earnings DateMar 01, 2022 - Mar 07, 2022
Forward Dividend & Yield2.00 (1.17%)
Ex-Dividend DateApr 29, 2022
1y Target Est160.76
  • Business Wire

    Finalization of Vifor Pharma acquisition

    MELBOURNE, Australia & ST. GALLEN, Switzerland, August 02, 2022--Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220801005796/en/

  • Business Wire

    Extension of the postponement of the settlement of Vifor Pharma tender offer

    MELBOURNE, Australia & ST. GALLEN, Switzerland, July 13, 2022--Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220712006199/en/

  • Reuters

    UPDATE 1-EU regulators investigate Vifor Pharma over anti-competitive behaviour

    EU antitrust regulators are investigating whether Vifor Pharma, which is being acquired by CSL Ltd, disparaged its rival Pharmacosmos in order to hinder competition to its blockbuster iron medicine Ferinject. The European Commission, which opened the probe on Monday, said it has indications of this behaviour going on for many years, which may be in breach of EU rules against companies abusing their dominant position. The EU competition enforcer said it was concerned that Vifor Pharma pursued a misleading communication campaign, primarily targeting healthcare professionals.

Advertisement
Advertisement